SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Grashoff Christopher L.

(Last) (First) (Middle)
C/O OPTION CARE HEALTH, INC.
3000 LAKESIDE DRIVE, SUITE 300N

(Street)
BANNOCKBURN IL 60015

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
12/06/2023
3. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Growth Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 16,609(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (2) 02/23/2031 Common Stock 4,904 $18.97 D
Employee Stock Option (right to buy) (3) 10/21/2031 Common Stock 8,974 $25.75 D
Employee Stock Option (right to buy) (4) 02/17/2032 Common Stock 4,052 $23.96 D
Employee Stock Option (right to buy) (5) 02/22/2033 Common Stock 7,956 $28.86 D
Explanation of Responses:
1. Includes (i) 4,332 restricted stock units that vest as to 25% of the underlying shares of Common Stock on each of February 22, 2024, February 22, 2025, February 22, 2026 and February 22, 2027, (ii) 5,193 restricted stock units that vest on May 19, 2024 (iii) 2,088 restricted stock units that vested as to 25% of the underlying shares of Common Stock on February 17, 2023 and that will vest as to 25% of the underlying shares of Common Stock on February 17, 2024, February 17, 2025 and February 17, 2026, (iv) 3,107 restricted stock units that vest on October 21, 2024, and (v) 2,504 restricted stock units that vested as to 50% of the underlying shares of Common Stock on February 23, 2023, and that will vest as to 25% of the underlying shares of Common Stock on each of February 23, 2024 and February 23, 2025.
2. 2,452 stock options vested on February 23, 2023; 1,226 stock options vest on February 23, 2024 and 1,226 vest on February 23, 2025.
3. Stock option vests in full on October 21, 2024.
4. 1,013 stock options vested on February 17, 2023; 1,013 stock options vest on February 17, 2024, 1,013 stock options vest on February 17, 2025 and 1,013 stock options vest on February 17, 2026.
5. Stock option vests in four equal annual installments starting on February 22, 2024.
Remarks:
Exhibit List: Exhibit 24-Power of Attorney
/s/ Sarah Kim, attorney-in-fact for Mr. Grashoff 12/15/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.